These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24906862)

  • 21. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK; Munoz B; Mkocha H; Gaydos CA; Quinn TC
    J Infect Dis; 2011 Jul; 204(2):268-73. PubMed ID: 21673038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia.
    Harding-Esch EM; Sillah A; Edwards T; Burr SE; Hart JD; Joof H; Laye M; Makalo P; Manjang A; Molina S; Sarr-Sissoho I; Quinn TC; Lietman T; Holland MJ; Mabey D; West SK; Bailey R;
    PLoS Negl Trop Dis; 2013; 7(6):e2115. PubMed ID: 23785525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Foster A; Bailey RL; Mabey DC
    Lancet; 2005 Oct; 366(9493):1296-300. PubMed ID: 16214600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
    Harding-Esch E; Jofre-Bonet M; Dhanjal JK; Burr S; Edwards T; Holland M; Sillah A; West S; Lietman T; Keenan J; Mabey D; Bailey R
    PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003670. PubMed ID: 25901349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW; Holland MJ; Alexander ND; Massae PA; Aguirre A; Natividad-Sancho A; Molina S; Safari S; Shao JF; Courtright P; Peeling RW; West SK; Bailey RL; Foster A; Mabey DC
    N Engl J Med; 2004 Nov; 351(19):1962-71. PubMed ID: 15525721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mass treatment and the effect on the load of Chlamydia trachomatis infection in a trachoma-hyperendemic community.
    West ES; Munoz B; Mkocha H; Holland MJ; Aguirre A; Solomon AW; Bailey R; Foster A; Mabey D; West SK
    Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):83-7. PubMed ID: 15623758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensive insecticide spraying for fly control after mass antibiotic treatment for trachoma in a hyperendemic setting: a randomised trial.
    West SK; Emerson PM; Mkocha H; McHiwa W; Munoz B; Bailey R; Mabey D
    Lancet; 2006 Aug; 368(9535):596-600. PubMed ID: 16905024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands.
    Marks M; Bottomley C; Tome H; Pitakaka R; Butcher R; Sokana O; Kako H; Solomon AW; Mabey DC
    Sex Transm Infect; 2016 Jun; 92(4):261-5. PubMed ID: 26888658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trachoma and ocular Chlamydia trachomatis rates in children in trachoma-endemic communities enrolled for at least three years in the Tanzania National Trachoma Control Programme.
    Mkocha H; Munoz B; West S
    Tanzan J Health Res; 2009 Jul; 11(3):103-10. PubMed ID: 20734706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for active trachoma and Chlamydia trachomatis infection in rural Ethiopia after mass treatment with azithromycin.
    Edwards T; Harding-Esch EM; Hailu G; Andreason A; Mabey DC; Todd J; Cumberland P
    Trop Med Int Health; 2008 Apr; 13(4):556-65. PubMed ID: 18282237
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted Mass Azithromycin Distribution for Trachoma: A Community-Randomized Trial (TANA II).
    Mahmud H; Haile BA; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Liu Z; Callahan EK; Cotter SY; Varnado NE; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Clin Infect Dis; 2023 Aug; 77(3):388-395. PubMed ID: 37021692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
    Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
    Burton MJ; Holland MJ; Makalo P; Aryee EA; Sillah A; Cohuet S; Natividad A; Alexander ND; Mabey DC; Bailey RL
    PLoS Negl Trop Dis; 2010 Oct; 4(10):. PubMed ID: 20957147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration.
    Goodhew EB; Morgan SM; Switzer AJ; Munoz B; Dize L; Gaydos C; Mkocha H; West SK; Wiegand RE; Lammie PJ; Martin DL
    BMC Infect Dis; 2014 Apr; 14():216. PubMed ID: 24755001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for contamination with C. trachomatis in the household environment of children with active Trachoma: A cross-sectional study in Kongwa, Tanzania.
    West SK; Nanji AA; Mkocha H; Munoz B; Gaydos C; Quinn TC
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007834. PubMed ID: 31869324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Constant ocular infection with Chlamydia trachomatis predicts risk of scarring in children in Tanzania.
    Wolle MA; Muñoz BE; Mkocha H; West SK
    Ophthalmology; 2009 Feb; 116(2):243-7. PubMed ID: 19091415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district.
    Odonkor M; Naufal F; Munoz B; Mkocha H; Kasubi M; Wolle M; West S
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009343. PubMed ID: 33861754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two-day dosing versus one-day dosing of azithromycin in children with severe trachoma in Tanzania.
    Campbell JP; Mkocha H; Munoz B; West SK
    Ophthalmic Epidemiol; 2012 Feb; 19(1):38-42. PubMed ID: 22273357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.